Now showing items 1-3 of 3
Screening for renal disease in a remote Aboriginal community using the Bayer DCA 2000
(Australian Institute of Medical Scientists, 2001)
End-stage renal disease among Aboriginal Australians has reached alarming proportions during the past decade. The early identification of this disease through community screening programs is a key strategy in reducing the ...
Assessment of the point-of-care Cholestech Lipid Analyser for lipid screening in Aboriginal communities
(Australian Institute of Medical Scientists, 2002)
Cardiovascular disease is the leading cause of mortality in Aboriginal Australians. Screening for cardiovascular disease risk factors, notably elevated blood lipids, is urgently needed. The small portable Cholestech machine ...
Point-of-care testing in the Aboriginal community
(Australian Institute of Medical Scientists, 2003)
This article documents experiences working in the field of Aboriginal health. The principle focus of the work is the application of Point-of-Care (POC) technology for the early detection and management of chronic diseases ...